SR-0379

N/A

Report date: 2024/08/27 11:13:29
NME

Base Information

Drug NameSR-0379
Drug Alias NameSR-0379
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionPI3-kinase class I inhibitorsSerine/threonine-protein kinase AKT1 inhibitorsSerine/threonine-protein kinase mTOR inhibitors
TargetsPI3-kinase class ISerine/threonine-protein kinase AKT1Serine/threonine-protein kinase mTOR
Therapy Area/IndicationsSkin Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesFunPep Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFunPep Co LtdShionogi & Co Ltd
Inactive CompaniesN/A
Active IndicationsSkin Ulcer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A